Results 41 to 50 of about 629,937 (377)

Dental management considerations for the patient with an acquired coagulopathy. Part 1: Coagulopathies from systemic disease [PDF]

, 2003
Current teaching suggests that many patients are at risk for prolonged bleeding during and following invasive dental procedures, due to an acquired coagulopathy from systemic disease and/or from medications.
A Barber, AB Lumb, AD Kaye, AGG Turpie, AH Friedlander, AI Schafer, AM Ziffer, AS Gewirtz, AT Mailloux, BS Coller, C Kearon, CA Petruff, CH Mielke Jr., CL Norred, D Blinder, D Deykin, DB Petitti, DF Pawlak, DM Eisenberg, EM Hylek, F Catella-Lawson, FE Silverstein, G Palareti, G Russo, H Bagheri, H Ogiuchi, IW Scopp, J Gibson, J Harenberg, J Hirsh, J Hirsh, J Hirsh, J Leitch, J Marshall, JA Oates, JA Ware, JC O'Laughlin, JH Campbell, JN George, JN Saour, JR Vane, K Webster, L Bodner, L Mengle-Gaw, LC Tsen, LS Simon, M Akbarian, M Hurlen, M Levine, MH Eckman, MH Eckman, MJ Steinburg, MJ Troulis, MJ Wahl, MJ Wahl, MK Ang-Lee, MMW Koopman, N May, OR Beirne, P B Lockhart, P Devani, PC Amrein, PJ Sharis, R Benoliel, R De Caterina, R Hull, R Mulligan, R Mulligan, R Stern, RA Seymour, RE Alexander, RH White, RI Shorr, RT Weibert, S Cronberg, S Goldman, S H Pond, S Lippert, SC Cannegieter, SD Fihn, SE Lind, SE Lind, SI Rapaport, SJ Behrman, SR Cox, SS De Rossi, T Bandrowsky, TP Rooney, VA Ferraris, WR Bartle, WW Herman   +90 more
core   +1 more source

The use of platelet-rich plasma in treatment of olfactory dysfunction: A pilot study. [PDF]

, 2020
BackgroundOlfactory dysfunction is a prevalent problem with a significant impact on quality of life and increased mortality. Limited effective therapies exist.
Mundy, David C, Patel, Zara M, Yan, Carol H   +2 more
core   +1 more source

A novel likely pathogenic variant in the RUNX1 gene as the cause of congenital thrombocytopenia

Balkan Journal of Medical Genetics, 2023
Heterozygous pathogenic and likely pathogenic sequence variants in the RUNX1 (Runt-related Transcription Factor 1) gene are a common genetic cause of decreased platelet count and/or platelet dysfunction and an increased risk of developing myelodysplasia ...
Despotović M, Pereza N, Peterlin B, Ostojić S, Golob B, Maver A, Roganović J   +6 more
doaj   +1 more source

Inherited platelet disorders: toward DNA-based diagnosis.

Blood, 2016
Variations in platelet number, volume, and function are largely genetically controlled, and many loci associated with platelet traits have been identified by genome-wide association studies (GWASs).(1) The genome also contains a large number of rare ...
C. Lentaigne, K. Freson, M. Laffan, E. Turro, W. Ouwehand   +4 more
semanticscholar   +1 more source

Sticky Platelet Syndrome in Patients with Uninduced Venous Thrombosis

Turkish Journal of Hematology, 2013
OBJECTIVE: Sticky platelet syndrome (SPS) is a common autosomal dominant inherited platelet disorder. SPS is characterized by platelet hyperreactivity and is associated with arterial and venous thrombosis.
Emre Tekgündüz, Muzaffer Demir, Seval Akpınar, Alev Akyol Erikçi, Erman Öztürk, Onur Kırkızlar   +5 more
doaj   +1 more source

Flow cytometry for evaluating platelet immunophenotyping and function in patients with thrombocytopenia

Tzu Chi Medical Journal, 2022
Platelets play an essential role in primary hemostasis through bleeding and thromboembolism. Thus, the diagnosis or evaluation of impaired hereditary, acquired, and drug-related platelet dysfunction has become imperative.
Chih-Lung Shen, Yi-Feng Wu
doaj   +1 more source

A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.

Blood, 2016
Inherited bleeding, thrombotic, and platelet disorders (BPDs) are diseases that affect ∼300 individuals per million births. With the exception of hemophilia and von Willebrand disease patients, a molecular analysis for patients with a BPD is often ...
Ilenia Simeoni, J. Stephens, Fengyuan Hu, Sri V. V. Deevi, K. Megy, T. Bariana, C. Lentaigne, Sol Schulman, S. Sivapalaratnam, Minka J. A. Vries, S. Westbury, D. Greene, S. Papadia, M. Alessi, A. Attwood, M. Ballmaier, G. Baynam, E. Bermejo, M. Bertoli, P. Bray, L. Bury, M. Cattaneo, P. Collins, L. Daugherty, R. Favier, D. French, B. Furie, M. Gattens, M. Germeshausen, C. Ghevaert, A. Goodeve, J. Guerrero, D. Hampshire, D. Hart, J. Heemskerk, Y. Henskens, M. Hill, Nancy Hogg, J. Jolley, W. Kahr, A. Kelly, R. Kerr, Myrto A. Kostadima, S. Kunishima, Michele P. Lambert, R. Liesner, José A López, R. Mapeta, M. Mathias, C. Millar, A. Nathwani, M. Neerman-Arbez, A. Nurden, P. Nurden, M. Othman, K. Peerlinck, D. Perry, Pawan Poudel, P. Reitsma, M. Rondina, P. Smethurst, W. Stevenson, A. Szkotak, Salih Tuna, C. van Geet, Deborah Whitehorn, D. Wilcox, Bin Zhang, S. Revel-Vilk, P. Gresele, D. Bellissimo, C. Penkett, M. Laffan, A. Mumford, A. Rendon, K. Gomez, K. Freson, W. Ouwehand, E. Turro   +78 more
semanticscholar   +1 more source

Physico-Biochemical comparative study for Thyroid disorder patients in Ramadi city [PDF]

مجلة جامعة الانبار للعلوم الصرفة, 2015
The study aims at determining the impact of thyroid disorders in some blood and biochemical changes to try determine changes in some of the functions of the body as a result of these disorders, whether physiological or biochemical.
Muthana M. Awad, Abbas A. Hamdi
doaj   +1 more source

Curated disease‐causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH

Journal of Thrombosis and Haemostasis, 2019
1Department of Haematology, University of Cambridge. Cambridge, UK 2NIHR BioResource, Cambridge University Hospitals, Cambridge, UK 3NHS Blood and Transplant, Cambridge, UK 4Department of Medicine, Section of Internal and Cardiovascular Medicine ...
K. Megy, K. Downes, Ilenia Simeoni, L. Bury, Joannella Morales, R. Mapeta, D. Bellissimo, P. Bray, A. Goodeve, P. Gresele, Michele P. Lambert, P. Reitsma, W. Ouwehand, K. Freson   +13 more
semanticscholar   +1 more source

Successful treatment of refractory gastrointestinal bleeding by systemic (oral) ankaferd blood stopper in a patient with Glanzmann thrombasthenia [PDF]

, 2015
Background: Glanzmann Thrombasthenia (GT) is a genetic platelet dysfunction and a life threatening disease. Ankaferd Blood Stopper (ABS) is a topical hemostatic agent of herbal origin which has been recently made available for clinical use.
Doğu, Mehmet Hilmi, Hacıoğlu, Sibel Kabukçu, Keskin, Ali, Sarı, İsmail   +3 more
core   +2 more sources